SI
BIIB icon

Sava Infond’s Biogen BIIB Stock Holding History

Sava Infond’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$178K Hold
825
– – 0.01% 192
2026
Q1 		$151K Hold
825
– – 0.02% 197
2025
Q4 		$145K Hold
825
– – 0.02% 193
2025
Q3 		$116K Sell
825
-825
-50% -$112K 0.02% 189
2025
Q2 		$207K Hold
1,650
– – 0.03% 169
2025
Q1 		$226K Hold
1,650
– – 0.04% 163
2024
Q4 		$252K Buy
+1,650
New +$278K 0.04% 158

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
NGM
North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Sava Infond's BIIB Position: Q2 2026 in Review

Sava Infond held its Biogen (BIIB) position steady in Q2 2026 at 825 shares worth $178K. The position accounts for 0.01% of the portfolio, ranked #192.

Sava Infond first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. The position peaked at $252K in Q4 2024. 189 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Sava Infond held 825 shares of Biogen worth $178K as of Q2 2026.
  • Sava Infond left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.01% of Sava Infond's portfolio in Q2 2026, its #192 holding.
  • Sava Infond first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • Sava Infond's Biogen position peaked at $252K in Q4 2024.
  • 189 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.